News - Boehringer Ingelheim

Filter

Current filters:

Boehringer Ingelheim

Popular Filters

101 to 125 of 167 results

New LABA/LAMA drugs set to fracture COPD market

10-10-2012

The drug market for chronic obstructive pulmonary disease (COPD) therapies will become more fractured…

AdvairBoehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingPfizerPharmaceuticalRespiratory and PulmonarySpiriva

Promising data on insulin degludec and LY2605541 at EASD meeting

03-10-2012

New data presented yesterday at the Annual Meeting of the European Association for the Study of Diabetes…

Boehringer IngelheimDegludecDiabetesEli LillyLY2605541Novo NordiskPharmaceuticalResearch

Top executive appointments at Boehringer and Bristol-Myers

01-10-2012

German family-owned drug major Boehringer Ingelheim says that Engelbert Tjeenk Willink, a member of the…

Boehringer IngelheimBristol-Myers SquibbManagementPharmaceutical

NICE final guidance backs NHS use of Boehringer Ingelheim's Actilyse

25-09-2012

In final guidance issued this morning (September 26), UK drugs watchdog the National Institute for Health…

ActilyseBoehringer IngelheimCardio-vascularEuropePharmaceuticalPricingRegulation

Boehringer Ingelheim files first oncology compound, afatinib, for EU approval

21-09-2012

German family-owned drug major Boehringer Ingelheim said yesterday that it has submitted a Marketing…

afatinibBoehringer IngelheimEuropeOncologyPharmaceuticalRegulation

Boehringer reveals new data on olodaterol and tiotropium combo at ERS

04-09-2012

German family-owned drug major Boehringer Ingelheim for the first time presented data from a Phase II…

Boehringer IngelheimolodaterolPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

Boehringer's Spiriva has advantages for patients with COPD, says IQWiG

29-08-2012

In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD),…

Boehringer IngelheimEuropePharmaceuticalRegulationRespiratory and PulmonarySpiriva

NICE issues draft guidance on Boehringer's Actilyse

27-08-2012

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) issued draft guidance…

ActilyseBoehringer IngelheimCardio-vascularEuropePharmaceuticalRegulation

Pradaxa efficacy and cost effectiveness advantages over Xarelto

27-08-2012

Indirect comparison based on the RE-LYtrial (for family owned German drugmaker Boehringer Ingelheim's…

BayerBoehringer IngelheimCardio-vascularPharmaceuticalPradaxaPricingResearchXarelto

FDA approves expanded use of Boehringer and Lilly's Tradjenta

20-08-2012

German family-owned drug major Boehringer Ingelheim and US partner and Eli Lilly (NYSE: LLY) said on…

Boehringer IngelheimDiabetesEli LillyNorth AmericaPharmaceuticalRegulationTradjenta

Leading dopamine agonists will continue to dominate Parkinson's market

19-08-2012

The leading dopamine agonists, pramipexole (Boehringer Ingelheim's Mirapex/Mirapexin/Sifrol/BI-Sifrol,…

Boehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingMirapexNeuproNeurologicalPharmaceuticalRequipRytaryUCB

Boehringer Ingelheim first-half 2012 sales up 6.8%

15-08-2012

German family-owned drug major Boehringer Ingelheim yesterday reported that, for the first half of 2012,…

Boehringer IngelheimFinancialPharmaceutical

XOMA and Servier sign manufacturing deal with Boehringer for gevokizumab

06-08-2012

US therapeutic antibody discovery firm XOMA Corp (Nasdaq: XOMA) its partner France's Laboratoires Servier…

Boehringer IngelheimgevokizumabLicensingOphthalmicsPharmaceuticalProductionServierXOMA Corp

Boehringer and Lilly's combo diabetes drug Jentadueto gains EU approval

26-07-2012

Independent German drug major Boehringer Ingelheim and US partner Eli Lilly (NYSE: LLY) received Marketing…

Boehringer IngelheimDiabetesEli LillyEuropeJentaduetoPharmaceuticalRegulation

Boehringer Ingelheim acquires Funxional products

24-07-2012

German family-controlled drug major Boehringer Ingelheim has entered an agreement to acquire the global…

Anti-Arthritics/RheumaticsBoehringer IngelheimFunxional TherapeuticsFX125LLicensingPharmaceuticalRespiratory and Pulmonarysomatotaxin

Lilly/Boehringer Ingelheim's Cymbalta now fibromyalgia market leader in USA

22-07-2012

US drug major Eli Lilly (NYSE: LLY) and German independent Boehringer Ingelheim's Cymbalta (duloxetine)…

Boehringer IngelheimCymbaltaEli LillyGlobalLyricaMarkets & MarketingNeurologicalNorth AmericaPfizerPharmaceutical

Boehringer Ingelheim links with Harvard for unmet medical needs research

09-07-2012

Family-controlled German drug major Boehringer Ingelheim has established a translational research collaboration…

Antibiotics and Infectious diseasesBoehringer IngelheimOncologyPharmaceuticalResearch

More news from American Diabetes Association meeting

13-06-2012

Ongoing news from the American Diabetes Association meeting in Philadelphia (see also The Pharma Letter…

Boehringer IngelheimDiabetesEli LillyLantusLY2605541PharmaceuticalResearchSanofi

Highlights of American Diabetes Association meeting

11-06-2012

The weekend saw a flood of new data on diabetes drug candidates and currently approved treatments presented…

Boehringer IngelheimDegludecDiabetesEli LillyempagliflozinLyxumiaNovo NordiskPharmaceuticalResearchSanofiTradjentaVictoza

Boehringer Ingelheim updates US labelling of Pradaxa for stroke

07-06-2012

Independent German drug major Boehringer Ingelheim has updated the US prescribing information for Pradaxa…

Boehringer IngelheimCardio-vascularNorth AmericaPharmaceuticalPradaxaRegulation

Flood of new cancer drug data presented at ASCO; nearly 1,000 being tested

04-06-2012

The annual prestigious American Society of Clinical Oncology (ASCO) meeting taking place in Chicago,…

afatinibBiotechnologyBoehringer IngelheimGenentechJanssenJohnson & JohnsonOncologyPharmaceuticalResearchRochetrastuzumab emtansineZytiga

EMA unit backs approval of Jentadueto; Agency updates on Pradaxa

28-05-2012

Independent German drug major Boehringer Ingelheim and US partner Eli Lilly (NYSE: LLY) have received…

Boehringer IngelheimCardio-vascularDiabetesEli LillyEuropeJentaduetoPharmaceuticalPradaxaRegulation

UK academia-pharma collaboration attracts £14.4 million funding

13-05-2012

In the UK, the University of Dundee and the Medical Research Council (MRC) have announced new funding…

AstraZenecaBoehringer IngelheimEuropeFinancialGlaxoSmithKlineJohnson & JohnsonMerck SeronoPfizerPharmaceuticalResearch

101 to 125 of 167 results

Back to top